These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 18286380)

  • 41. Pap screening and knowledge of risk factors for cervical cancer in Chinese women in British Columbia, Canada.
    Hislop TG; Teh C; Lai A; Ralston JD; Shu J; Taylor VM
    Ethn Health; 2004 Aug; 9(3):267-81. PubMed ID: 15370000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there a language divide in pap test use?
    Ponce NA; Chawla N; Babey SH; Gatchell MS; Etzioni DA; Spencer BA; Brown ER; Breen N
    Med Care; 2006 Nov; 44(11):998-1004. PubMed ID: 17063131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of laboratory reports to assess cervical cancer screening in a community.
    Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
    Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
    Hutchinson ML; Berger BM; Farber FL
    Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utilization of obstetrician-gynecologists and prevention of cervical cancer.
    Weisman CS; Celentano DD; Klassen AC; Rosenshein NB
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):373-7. PubMed ID: 3627584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing women's compliance with opportunistic cervical cancer screening: a randomized trial.
    Ward JE; Boyle K; Redman S; Sanson-Fisher RW
    Am J Prev Med; 1991; 7(5):285-91. PubMed ID: 1790034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effectiveness of cytology-based cervical cancer screening in the Colombian health system].
    Murillo R; Cendales R; Wiesner C; Piñeros M; Tovar S
    Biomedica; 2009 Sep; 29(3):354-61. PubMed ID: 20436987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
    Lynge E; Arffmann E; Poll P; Andersen PK
    Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
    Ogunbowale T; Lawoyin TO
    Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low rates of cervical cancer screening among urban immigrants: a population-based study in Ontario, Canada.
    Lofters AK; Moineddin R; Hwang SW; Glazier RH
    Med Care; 2010 Jul; 48(7):611-8. PubMed ID: 20548258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
    Sasagawa T
    Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
    Viikki M; Pukkala E; Hakama M
    Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variation in the cervical cancer screening compliance among women with disability.
    Chen LS; Chou YJ; Tsay JH; Lee CH; Chou P; Huang N
    J Med Screen; 2009; 16(2):85-90. PubMed ID: 19564521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Screening profile of women who have died from cervical cancer].
    Ejersbo D
    Ugeskr Laeger; 2008 Feb; 170(9):727-30. PubMed ID: 18307959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Campaign for cervical cancer screening with vaginal smears in women aged 50-69 years in Isère (France). Results of the first round (January 1991-June 1993)].
    Garnier A; Exbrayat C; Bolla M; Marron J; Winckel P; Billette de Villemeur A
    Bull Cancer; 1997 Aug; 84(8):791-5. PubMed ID: 9339183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.